Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis
- PMID: 24947526
- DOI: 10.1161/ATVBAHA.114.303416
Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis
Abstract
Objective: Aberrant regulation of the proliferation, survival, and migration of endothelial cells (ECs) is closely related to the abnormal angiogenesis that occurs in hypoxia-induced pathological situations, such as cancer and vascular retinopathy. Hypoxic conditions and the subsequent upregulation of hypoxia-inducible factor-1α and target genes are important for the angiogenic functions of ECs. Phospholipase D2 (PLD2) is a crucial signaling mediator that stimulates the production of the second messenger phosphatidic acid. PLD2 is involved in various cellular functions; however, its specific roles in ECs under hypoxia and in vivo angiogenesis remain unclear. In the present study, we investigated the potential roles of PLD2 in ECs under hypoxia and in hypoxia-induced pathological angiogenesis in vivo.
Approach and results: Pld2 knockout ECs exhibited decreased hypoxia-induced cellular responses in survival, migration, and thus vessel sprouting. Analysis of hypoxia-induced gene expression revealed that PLD2 deficiency disrupted the upregulation of hypoxia-inducible factor-1α target genes, including VEGF, PFKFB3, HMOX-1, and NTRK2. Consistent with this, PLD2 contributed to hypoxia-induced hypoxia-inducible factor-1α expression at the translational level. The roles of PLD2 in hypoxia-induced in vivo pathological angiogenesis were assessed using oxygen-induced retinopathy and tumor implantation models in endothelial-specific Pld2 knockout mice. Pld2 endothelial-specific knockout retinae showed decreased neovascular tuft formation, despite a larger avascular region. Tumor growth and tumor blood vessel formation were also reduced in Pld2 endothelial-specific knockout mice.
Conclusions: Our findings demonstrate a novel role for endothelial PLD2 in the survival and migration of ECs under hypoxia via the expression of hypoxia-inducible factor-1α and in pathological retinal angiogenesis and tumor angiogenesis in vivo.
Keywords: angiogenesis; endothelial cell; hypoxia-inducible factor-1; phospholipase D2.
© 2014 American Heart Association, Inc.
Similar articles
-
LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):350-60. doi: 10.1161/ATVBAHA.115.306713. Epub 2015 Dec 3. Arterioscler Thromb Vasc Biol. 2016. PMID: 26634655 Free PMC article.
-
SNRK (Sucrose Nonfermenting 1-Related Kinase) Promotes Angiogenesis In Vivo.Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):373-385. doi: 10.1161/ATVBAHA.117.309834. Epub 2017 Dec 14. Arterioscler Thromb Vasc Biol. 2018. PMID: 29242271 Free PMC article.
-
IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis.Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2638-46. doi: 10.1161/ATVBAHA.115.306543. Epub 2015 Oct 29. Arterioscler Thromb Vasc Biol. 2015. PMID: 26515414
-
Roles of Hypoxia Response in Retinal Development and Pathophysiology.Keio J Med. 2018 Mar 23;67(1):1-9. doi: 10.2302/kjm.2017-0002-IR. Epub 2017 Jun 6. Keio J Med. 2018. PMID: 28592747 Review.
-
[Adrenomedullin-Receptor Activity-modifying Protein 2 (RAMP2) System in Retinal Angiogenesis].Nippon Ganka Gakkai Zasshi. 2015 Nov;119(11):761-71. Nippon Ganka Gakkai Zasshi. 2015. PMID: 26685480 Review. Japanese.
Cited by
-
Targeting Phospholipase D4 Attenuates Kidney Fibrosis.J Am Soc Nephrol. 2017 Dec;28(12):3579-3589. doi: 10.1681/ASN.2016111222. Epub 2017 Aug 16. J Am Soc Nephrol. 2017. PMID: 28814511 Free PMC article.
-
Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.J Exp Clin Cancer Res. 2024 Feb 26;43(1):57. doi: 10.1186/s13046-024-02988-y. J Exp Clin Cancer Res. 2024. PMID: 38403587 Free PMC article.
-
The phospholipase D superfamily as therapeutic targets.Trends Pharmacol Sci. 2015 Mar;36(3):137-44. doi: 10.1016/j.tips.2015.01.001. Epub 2015 Feb 3. Trends Pharmacol Sci. 2015. PMID: 25661257 Free PMC article. Review.
-
Phospholipase D2 loss results in increased blood pressure via inhibition of the endothelial nitric oxide synthase pathway.Sci Rep. 2017 Aug 22;7(1):9112. doi: 10.1038/s41598-017-09852-4. Sci Rep. 2017. PMID: 28831159 Free PMC article.
-
Mammalian phospholipase D: Function, and therapeutics.Prog Lipid Res. 2020 Apr;78:101018. doi: 10.1016/j.plipres.2019.101018. Epub 2019 Dec 9. Prog Lipid Res. 2020. PMID: 31830503 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases